niacinamide has been researched along with Cardiovascular Stroke in 47 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Salutary effect of nicorandil, a K+ adenosine triphosphate channel opener, on restoration of myocardial blood flow and functional improvement after coronary revascularization was investigated in 20 patients with first anterior acute myocardial infarction." | 9.08 | Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. ( Hirayama, A; Hori, M; Ishikura, F; Kitakaze, M; Kodama, K; Komamura, K; Lim, YJ; Masuyama, T; Sakata, Y, 1997) |
| "This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction." | 9.08 | Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. ( Daikoku, S; Goto, Y; Haze, K; Itoh, A; Kobayashi, Y; Miyazaki, S; Nonogi, H; Ohshima, S, 1998) |
| "Mice treated with sorafenib or vehicle for 3 weeks underwent induced myocardial infarction (MI) after 1 week of treatment." | 7.80 | Sorafenib cardiotoxicity increases mortality after myocardial infarction. ( Barbe, M; Berretta, RM; Dunn, J; Duran, JM; Force, T; Gao, E; Gross, P; Houser, SR; Husain, S; Kubo, H; Lal, H; Makarewich, CA; Sharp, TE; Starosta, T; Trappanese, D; Vagnozzi, RJ; Yu, D, 2014) |
| "Adjunctive intracoronary administration of nicorandil, an ATP-sensitive potassium channel opener, after successful coronary revascularization was performed in a 54-year-old patient with acute myocardial infarction." | 7.69 | Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction. ( Hasegawa, S; Hirayama, A; Ishikura, F; Kodama, K; Komamura, K; Sakata, Y, 1997) |
| "Hemodynamic effects of nicorandil on exercise-induced impairment of left ventricular function were studied in nine patients with old myocardial infarction but without angina pectoris." | 7.67 | Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction. ( Horisawa, T; Iwase, M; Kamihara, S; Koide, M; Miyahara, T; Noda, S; Tsunekawa, A; Tsuzuki, M; Yokota, M; Yoshida, J, 1987) |
| "The effects of nicorandil, a new antianginal drug, on size of myocardial infarction were studied in anesthetized, open-chest dogs after left anterior descending coronary artery occlusion." | 7.67 | Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1988) |
| "Treatment with sorafenib prolongs progression-free survival in patients with advanced clear-cell renal cell carcinoma." | 5.42 | [Three Patients with Acute Myocardial Infarction Associated with Targeted Therapy of Sorafenib for Metastatic Renal Cell Carcinoma : Case Report]. ( Deguchi, T; Horie, K; Kato, T; Kawata, K; Kikuchi, M; Miyazaki, T; Mizutani, K; Nakano, M; Seike, K; Takagi, K; Takai, M; Tsuchiya, T; Ushikoshi, H; Yasuda, M; Yokoi, S, 2015) |
| "Heart failure was produced by myocardial infarction, and was associated with markedly increased AMPK and SIRT1 protein levels." | 5.40 | Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. ( Gu, XS; Lei, JP; Li, L; Su, DF; Wang, ZB; Ye, Z; Zheng, X, 2014) |
| "Sorafenib is a multikinase inhibitor that targets signaling pathways necessary for cellular proliferation and survival." | 5.35 | Sorafenib-induced acute myocardial infarction due to coronary artery spasm. ( Arima, Y; Fukushima, H; Nakamura, S; Noda, K; Ogawa, H; Oshima, S; Shono, M; Taniguchi, I, 2009) |
| "Salutary effect of nicorandil, a K+ adenosine triphosphate channel opener, on restoration of myocardial blood flow and functional improvement after coronary revascularization was investigated in 20 patients with first anterior acute myocardial infarction." | 5.08 | Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. ( Hirayama, A; Hori, M; Ishikura, F; Kitakaze, M; Kodama, K; Komamura, K; Lim, YJ; Masuyama, T; Sakata, Y, 1997) |
| "This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction." | 5.08 | Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. ( Daikoku, S; Goto, Y; Haze, K; Itoh, A; Kobayashi, Y; Miyazaki, S; Nonogi, H; Ohshima, S, 1998) |
| "Mice treated with sorafenib or vehicle for 3 weeks underwent induced myocardial infarction (MI) after 1 week of treatment." | 3.80 | Sorafenib cardiotoxicity increases mortality after myocardial infarction. ( Barbe, M; Berretta, RM; Dunn, J; Duran, JM; Force, T; Gao, E; Gross, P; Houser, SR; Husain, S; Kubo, H; Lal, H; Makarewich, CA; Sharp, TE; Starosta, T; Trappanese, D; Vagnozzi, RJ; Yu, D, 2014) |
| "Adjunctive intracoronary administration of nicorandil, an ATP-sensitive potassium channel opener, after successful coronary revascularization was performed in a 54-year-old patient with acute myocardial infarction." | 3.69 | Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction. ( Hasegawa, S; Hirayama, A; Ishikura, F; Kodama, K; Komamura, K; Sakata, Y, 1997) |
| "Hemodynamic effects of nicorandil on exercise-induced impairment of left ventricular function were studied in nine patients with old myocardial infarction but without angina pectoris." | 3.67 | Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction. ( Horisawa, T; Iwase, M; Kamihara, S; Koide, M; Miyahara, T; Noda, S; Tsunekawa, A; Tsuzuki, M; Yokota, M; Yoshida, J, 1987) |
| "The effects of nicorandil, a new antianginal drug, on size of myocardial infarction were studied in anesthetized, open-chest dogs after left anterior descending coronary artery occlusion." | 3.67 | Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1988) |
| "Nicorandil and diltiazem were both found to decrease the frequency of anginal attacks and the consumption of nitroglycerin tablets (P < 0." | 2.67 | A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. ( Blin, P; Guermonprez, JL; Peterlongo, F, 1993) |
| "Treatment with sorafenib prolongs progression-free survival in patients with advanced clear-cell renal cell carcinoma." | 1.42 | [Three Patients with Acute Myocardial Infarction Associated with Targeted Therapy of Sorafenib for Metastatic Renal Cell Carcinoma : Case Report]. ( Deguchi, T; Horie, K; Kato, T; Kawata, K; Kikuchi, M; Miyazaki, T; Mizutani, K; Nakano, M; Seike, K; Takagi, K; Takai, M; Tsuchiya, T; Ushikoshi, H; Yasuda, M; Yokoi, S, 2015) |
| "Heart failure was produced by myocardial infarction, and was associated with markedly increased AMPK and SIRT1 protein levels." | 1.40 | Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. ( Gu, XS; Lei, JP; Li, L; Su, DF; Wang, ZB; Ye, Z; Zheng, X, 2014) |
| "Sorafenib is a multikinase inhibitor that targets signaling pathways necessary for cellular proliferation and survival." | 1.35 | Sorafenib-induced acute myocardial infarction due to coronary artery spasm. ( Arima, Y; Fukushima, H; Nakamura, S; Noda, K; Ogawa, H; Oshima, S; Shono, M; Taniguchi, I, 2009) |
| "Late treatment with nicorandil had no effect on infarct size (43." | 1.30 | Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. ( Baxter, GF; Imagawa, J; Yellon, DM, 1998) |
| "Pretreatment with nicorandil and glyceryl trinitrate caused a marked reduction in myocardial infarct size expressed as percent of the area at risk [NC/pre group, 7." | 1.29 | Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. ( Gross, GJ; Mizumura, T; Nithipatikom, K, 1995) |
| " Adverse events usually occurred early in the course of treatment." | 1.29 | Safety profile of an anti-anginal agent with potassium channel opening activity: an overview. ( Roland, E, 1993) |
| "Nicorandil is a compound with hybrid properties of nitrates and adenosine triphosphate (ATP)-sensitive potassium channel (KATP) opening." | 1.29 | Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. ( Branzi, A; Galiè, N; Guarnieri, C; Magnani, B; Parlangeli, R; Traini, AM; Ussia, GP; Vaona, I; Zimarino, M, 1995) |
| "To study the effects of stepwise early treatment in variant angina pectoris, frequencies of cardiac events and complications were examined after three different types of treatment." | 1.28 | A new strategy for the reduction of acute myocardial infarction in variant angina. ( Fukuma, N; Hata, N; Hayakawa, H; Kishida, H; Saito, T; Tada, Y; Tetsuoh, Y; Yamazaki, Y; Yasutake, M, 1991) |
| "The myocardial infarction was shown to result in shifts of the smooth muscle contractile function which were similar to those in EPS, though being somewhat less pronounced." | 1.27 | [Disorders of contractile function and adrenoreactivity of the portal vein in emotionally-painful stress and experimental myocardial infarct and their prevention by means of membrane protectors]. ( Dosmagambetova, RS; Manukhina, EB; Meerson, FZ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (23.40) | 18.7374 |
| 1990's | 24 (51.06) | 18.2507 |
| 2000's | 3 (6.38) | 29.6817 |
| 2010's | 9 (19.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eltze, T | 1 |
| Boer, R | 1 |
| Wagner, T | 1 |
| Weinbrenner, S | 1 |
| McDonald, MC | 1 |
| Thiemermann, C | 2 |
| Bürkle, A | 1 |
| Klein, T | 1 |
| Zabielska, MA | 1 |
| Adamus, J | 1 |
| Kowalski, R | 1 |
| Gebicki, J | 1 |
| Slominska, EM | 1 |
| Khalpey, Z | 1 |
| Smolenski, RT | 1 |
| Pereverzev, DI | 1 |
| Simonova, NV | 1 |
| Dorovskikh, VA | 1 |
| Anokhina, RA | 1 |
| Lv, YX | 1 |
| Zhong, S | 1 |
| Tang, H | 1 |
| Luo, B | 1 |
| Chen, SJ | 1 |
| Chen, L | 1 |
| Zheng, F | 1 |
| Zhang, L | 1 |
| Wang, L | 2 |
| Li, XY | 1 |
| Yan, YW | 1 |
| Pan, YM | 1 |
| Jiang, M | 1 |
| Zhang, YE | 1 |
| Yang, JY | 1 |
| Guo, LY | 1 |
| Chen, SY | 1 |
| Wang, JN | 1 |
| Tang, JM | 1 |
| Gu, XS | 1 |
| Wang, ZB | 1 |
| Ye, Z | 1 |
| Lei, JP | 1 |
| Li, L | 1 |
| Su, DF | 1 |
| Zheng, X | 1 |
| Duran, JM | 1 |
| Makarewich, CA | 1 |
| Trappanese, D | 1 |
| Gross, P | 1 |
| Husain, S | 1 |
| Dunn, J | 1 |
| Lal, H | 1 |
| Sharp, TE | 1 |
| Starosta, T | 1 |
| Vagnozzi, RJ | 1 |
| Berretta, RM | 1 |
| Barbe, M | 1 |
| Yu, D | 1 |
| Gao, E | 1 |
| Kubo, H | 1 |
| Force, T | 1 |
| Houser, SR | 1 |
| Cheng, W | 1 |
| Wu, P | 1 |
| Du, Y | 1 |
| Wang, Y | 1 |
| Zhou, N | 1 |
| Ge, Y | 1 |
| Yang, Z | 1 |
| Takagi, K | 1 |
| Takai, M | 1 |
| Kawata, K | 1 |
| Horie, K | 1 |
| Kikuchi, M | 1 |
| Kato, T | 1 |
| Mizutani, K | 1 |
| Seike, K | 1 |
| Tsuchiya, T | 1 |
| Yasuda, M | 1 |
| Yokoi, S | 1 |
| Nakano, M | 1 |
| Ushikoshi, H | 1 |
| Miyazaki, T | 1 |
| Deguchi, T | 1 |
| Giribabu, N | 1 |
| Roslan, J | 1 |
| Rekha, SS | 1 |
| Salleh, N | 1 |
| Arima, Y | 1 |
| Oshima, S | 1 |
| Noda, K | 1 |
| Fukushima, H | 1 |
| Taniguchi, I | 1 |
| Nakamura, S | 1 |
| Shono, M | 1 |
| Ogawa, H | 1 |
| Livanov, GA | 1 |
| Amagyrov, VP | 1 |
| Batotsyrenov, BV | 1 |
| Lodiagin, AN | 1 |
| Batotsyrenova, KhV | 1 |
| Ogawa, K | 1 |
| Enomoto, I | 1 |
| Ito, T | 1 |
| Ban, M | 1 |
| Hashimoto, H | 1 |
| Sakai, K | 1 |
| Meerson, FZ | 1 |
| Manukhina, EB | 1 |
| Dosmagambetova, RS | 1 |
| Mizumura, T | 2 |
| Nithipatikom, K | 2 |
| Gross, GJ | 7 |
| Yao, Z | 2 |
| Pieper, GM | 2 |
| Auchampach, JA | 3 |
| Yamazaki, J | 2 |
| Iida, M | 2 |
| Igarashi, M | 1 |
| Hosoi, H | 2 |
| Ishiguro, S | 1 |
| Hou, M | 1 |
| Morishita, T | 2 |
| Nakano, H | 2 |
| Yabe, Y | 2 |
| Koyama, N | 2 |
| Guermonprez, JL | 1 |
| Blin, P | 1 |
| Peterlongo, F | 1 |
| Roland, E | 1 |
| Ohsawa, H | 1 |
| Uchi, T | 1 |
| Komatsu, H | 1 |
| Galiè, N | 1 |
| Guarnieri, C | 1 |
| Ussia, GP | 1 |
| Zimarino, M | 1 |
| Traini, AM | 1 |
| Parlangeli, R | 1 |
| Vaona, I | 1 |
| Branzi, A | 1 |
| Magnani, B | 1 |
| Ejima, J | 1 |
| Kaneda, K | 1 |
| Moriyama, H | 1 |
| Ohmura, I | 1 |
| Maruyama, T | 1 |
| Kaji, Y | 1 |
| Tsuda, Y | 1 |
| Kanaya, S | 1 |
| Fujino, T | 1 |
| Niho, Y | 1 |
| Kitakaze, M | 2 |
| Minamino, T | 1 |
| Node, K | 1 |
| Komamura, K | 3 |
| Shinozaki, Y | 1 |
| Chujo, M | 1 |
| Mori, H | 1 |
| Inoue, M | 1 |
| Hori, M | 2 |
| Kamada, T | 1 |
| Sakata, Y | 3 |
| Kodama, K | 2 |
| Ishikura, F | 2 |
| Hasegawa, S | 1 |
| Hirayama, A | 2 |
| Lim, YJ | 1 |
| Masuyama, T | 1 |
| Schultz, JE | 1 |
| Cavero, I | 1 |
| Rioufol, G | 1 |
| Ovize, M | 1 |
| Loufoua, J | 1 |
| Pop, C | 1 |
| André-Fouät, X | 1 |
| Minaire, Y | 1 |
| Imagawa, J | 1 |
| Baxter, GF | 1 |
| Yellon, DM | 1 |
| Ohno, Y | 1 |
| Minatoguchi, S | 1 |
| Uno, Y | 1 |
| Kariya, T | 1 |
| Arai, M | 1 |
| Yamashita, K | 1 |
| Fujiwara, T | 1 |
| Fujiwara, H | 1 |
| Kobayashi, Y | 1 |
| Goto, Y | 1 |
| Daikoku, S | 1 |
| Itoh, A | 1 |
| Miyazaki, S | 1 |
| Ohshima, S | 1 |
| Nonogi, H | 1 |
| Haze, K | 1 |
| Bernofsky, C | 1 |
| Nunez, R | 2 |
| Calva, E | 2 |
| Marsh, M | 1 |
| Marsch, M | 1 |
| Briones, E | 1 |
| López-Soriano, F | 1 |
| Maruyama, M | 1 |
| Warltier, DC | 2 |
| van Woerkens, LJ | 1 |
| Baas, NR | 1 |
| van der Giessen, WJ | 1 |
| Verdouw, PD | 1 |
| Dzizinskiĭ, AA | 3 |
| Katiubin, VP | 2 |
| Kishida, H | 1 |
| Tada, Y | 1 |
| Tetsuoh, Y | 1 |
| Yamazaki, Y | 1 |
| Saito, T | 1 |
| Fukuma, N | 1 |
| Hata, N | 1 |
| Yasutake, M | 1 |
| Hayakawa, H | 2 |
| Yokota, M | 2 |
| Tsuzuki, J | 1 |
| Inagaki, H | 1 |
| Watanabe, M | 1 |
| Matsunami, T | 1 |
| Sotobata, I | 1 |
| Hardman, HF | 1 |
| Horisawa, T | 1 |
| Iwase, M | 1 |
| Miyahara, T | 1 |
| Yoshida, J | 1 |
| Kamihara, S | 1 |
| Noda, S | 1 |
| Tsunekawa, A | 1 |
| Koide, M | 1 |
| Tsuzuki, M | 1 |
| Endo, T | 1 |
| Nejima, J | 1 |
| Kiuchi, K | 1 |
| Fujita, S | 1 |
| Kikuchi, K | 1 |
| Okumura, H | 1 |
| Ana'nev, AA | 1 |
| Fuks, AR | 1 |
| Severin, SE | 1 |
| Chazov, EI | 1 |
| Smetnev, AS | 1 |
| Petrova, LI | 1 |
| Tabak, VIa | 1 |
| Ivashchenko, AG | 1 |
| Zakin, AM | 1 |
5 trials available for niacinamide and Cardiovascular Stroke
| Article | Year |
|---|---|
A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Topics: Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Diltiazem; Dose-Response Relationship | 1993 |
Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Topics: Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary V | 1995 |
Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Contrast Media; Coronary Circulation; Coronary Vessels; Echocardiogr | 1997 |
Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction.
Topics: Acute Disease; Anti-Arrhythmia Agents; Humans; Injections, Intravenous; Myocardial Infarction; Myoca | 1998 |
[Effects of antioxidants and membrane protectors on clinical course and hemodynamics of patients with myocardial infarct].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chloroquine; Female; Humans; Male; Middle Age | 1992 |
42 other studies available for niacinamide and Cardiovascular Stroke
| Article | Year |
|---|---|
Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Topics: Animals; Cell Line; Cell Line, Tumor; Fibroblasts; Humans; Imidazoles; Isoquinolines; Kinetics; Male | 2008 |
Cardioprotective effect of N-methylnicotinamide salt of pyruvate in experimental model of cardiac hypoxia.
Topics: Animals; Apolipoproteins E; Cardiotonic Agents; Creatine Kinase; Electrocardiography; Heart; Hypoxia | 2018 |
[THE EFFECT OF CYTOFLAVIN ON PARAMETERS OF THE LEFT VENTRICULAR SYSTOLIC FUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION.]
Topics: Adult; Aged; Biomarkers; Cardiotonic Agents; Case-Control Studies; Coronary Vessels; Creatine Kinase | 2017 |
VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cell Movement; Cell Proliferation; | 2018 |
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Cells, Cultured; Heart Failure; Male; Mice; Myoca | 2014 |
Sorafenib cardiotoxicity increases mortality after myocardial infarction.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cats; Cell Proliferation; Cells, Cultured; Disease Models | 2014 |
Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction.
Topics: Animals; Diabetes Mellitus, Experimental; Energy Metabolism; Heart; Isoflavones; Male; Mice; Mice, I | 2015 |
[Three Patients with Acute Myocardial Infarction Associated with Targeted Therapy of Sorafenib for Metastatic Renal Cell Carcinoma : Case Report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Middle Aged; Mol | 2015 |
Methanolic seed extract of Vitis vinifera ameliorates oxidative stress, inflammation and ATPase dysfunction in infarcted and non-infarcted heart of streptozotocin-nicotinamide induced male diabetic rats.
Topics: Adenosine Triphosphatases; Animals; Diabetes Mellitus, Experimental; Grape Seed Extract; Inflammatio | 2016 |
Sorafenib-induced acute myocardial infarction due to coronary artery spasm.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Coronary Vasospasm; Humans; K | 2009 |
[Pharmacological correction of hypoxic and free-radical disorders in patients with acute myocardial infarction complicated by acute heart failure].
Topics: Acute Disease; Critical Care; Drug Combinations; Flavin Mononucleotide; Fluorocarbons; Free Radicals | 2010 |
SG-75 induction of increased coronary outflow and PGE1 from ischemic areas in dogs with experimental myocardial infarction.
Topics: Alprostadil; Animals; Coronary Circulation; Dinoprostone; Dogs; Indomethacin; Lactates; Myocardial I | 1982 |
[Disorders of contractile function and adrenoreactivity of the portal vein in emotionally-painful stress and experimental myocardial infarct and their prevention by means of membrane protectors].
Topics: Animals; Butylated Hydroxytoluene; Glucose; Humans; Male; Muscle, Smooth, Vascular; Myocardial Infar | 1984 |
Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Topics: Adenosine; Animals; Cell Movement; Coronary Circulation; Dogs; Female; Male; Myocardial Infarction; | 1995 |
The ATP-regulated potassium channel in ischemia-reperfusion injury.
Topics: Adenosine Triphosphate; Animals; Dogs; Glyburide; Ion Channel Gating; Myocardial Contraction; Myocar | 1994 |
Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Antihypertensive Ag | 1994 |
Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Coronary Circulation; Dihydropyridines; Dogs; Female; | 1993 |
Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Circulation; Drug Monitoring; Electrocardi | 1993 |
Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Circu | 1993 |
Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs.
Topics: Animals; Blood Pressure; Cardiac Output; Female; Glutathione; Heart Rate; Isosorbide Dinitrate; Male | 1995 |
Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs.
Topics: Adenosine; Animals; Dogs; Female; Glyburide; Ion Channel Gating; Male; Methylene Blue; Myocardial In | 1996 |
Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels.
Topics: 5'-Nucleotidase; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dogs; Enzyme Activation; | 1996 |
Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
Topics: Coronary Circulation; Coronary Vessels; Humans; Injections; Male; Middle Aged; Myocardial Infarction | 1997 |
Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Glyburide; Heart; Hemodynamics; Hypotension; Ischem | 1997 |
Ventricular fibrillation in preconditioned pig hearts: role of K+ATP channels.
Topics: Action Potentials; Animals; Blood Glucose; Blood Pressure; Glyburide; Heart; Heart Rate; Ischemic Pr | 1997 |
Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Hemodynamics; Ischemic Preconditioning, Myo | 1998 |
Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits.
Topics: Analysis of Variance; Animals; Blood Pressure; Dose-Response Relationship, Drug; Glyburide; Heart Ra | 1997 |
Inhibition of the activity of poly (ADP-ribose) polymerase in ischemia-reperfusion injury.
Topics: Animals; DNA Damage; Drug Design; Energy Metabolism; Enzyme Inhibitors; Feedback; Humans; Ischemia; | 2000 |
Vitamin therapy for infarction.
Topics: Humans; Myocardial Infarction; Niacinamide | 1979 |
Nicotinamide adenine dinucleotide degradation in infarcted cardiac muscle.
Topics: Animals; Dogs; Myocardial Infarction; Myocardium; NAD; NAD+ Nucleosidase; Niacinamide; Subcellular F | 1975 |
NAD glycohydrolase activity in hearts with acute experimental infarction.
Topics: Animals; Disease Models, Animal; Dogs; Myocardial Infarction; Myocardium; NAD; NAD+ Nucleosidase; Ni | 1976 |
Cardioprotective effects of nicorandil.
Topics: Animals; Benzopyrans; Coronary Circulation; Dihydropyridines; Dogs; Female; Heart; In Vitro Techniqu | 1992 |
Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Dihydropyridines; Hemodynamics; Myocardial Infarction | 1992 |
[Clinical course and necrotic area size in patients with myocardial infarct receiving combined treatment including antioxidants and membrane-protecting agents].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Therapy, Combination; Female; Humans; Mal | 1991 |
A new strategy for the reduction of acute myocardial infarction in variant angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris, Variant; Angioplasty, Balloon, Coronary; Calcium Ch | 1991 |
Effect of low grade exercise training and a vasodilator on cardiac function in patients with recent myocardial infarction.
Topics: Cardiac Output; Exercise Therapy; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarc | 1990 |
Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Female; Male; Myocardial Contraction; Myocardia | 1987 |
Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
Topics: Adult; Coronary Circulation; Exercise Test; Heart; Heart Ventricles; Hemodynamics; Humans; Male; Mid | 1987 |
Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs.
Topics: Animals; Coronary Disease; Dogs; Female; Hemodynamics; Male; Myocardial Infarction; Niacinamide; Nic | 1988 |
[Effect of membrane protectors on the diastolic function of the heart in patients with acute myocardial infarction].
Topics: Adult; Aged; Cell Membrane; Diastole; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardia | 1989 |
[Basic directions in the study of the biochemistry of the myocardium].
Topics: Adaptation, Physiological; Animals; Camphor; Cardiac Glycosides; Cardiomegaly; Cardiovascular Diseas | 1967 |
[Use of neuroleptoanalgesia with thalamonal in myocardial infarct patients during the painful period].
Topics: Adult; Aged; Angina Pectoris; Benperidol; Female; Humans; Male; Middle Aged; Myocardial Infarction; | 1969 |